Pacira BioSciences, Inc. Common Stock (PCRX) News
Latest headlines that mention PCRX, newest first · each headline opens the original publisher
- Last price
- $36.39
- Day change
- +44.40%
- Next earnings
- 2026-11-05
PCRX headlines
last 30 daysViatris pledged Thursday to buy small biotech company Pacira Biosciences for $1.65 billion, sending Pacira stock skyrocketing. The post Pacira Biosciences Snags $1.65 Billion Viatris Takeover Deal; Shares Fly appeared first on Investor's Business Daily .
The specialty pharmaceutical company is being acquired.
Viatris has agreed to buy pain-drug maker Pacira BioSciences for $1.65 billion in a deal that expands the healthcare company’s medicines portfolio.
Also mentioned with PCRX
30dHeadlines that tag both tickers
PCRX news alerts
Get an alert by email or push when a new headline mentions PCRX.
More news
News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.